December 15, 2025 - Health Technology Insights

December 15, 2025
HealthTech Media Room
HealthTech News, News, news

Abeona Therapeutics Announces Appointment of Mohamad Tabrizi as Chief Business Officer

Abeona Therapeutics Inc. announced the appointment of Mohamad Tabrizi, M.S., M.B.A., as Senior Vice President, Chief Business Officer (CBO). In this role, Mr. Tabrizi will lead the Company’s corporate...

December 15, 2025
HealthTech Media Room
HealthTech News, News, news

NeuroSigma Invests $1Million in 2nd Gen Monarch eTNS Manufacturing

Armstrong Asia of Singapore selected as NeuroSigma’s manufacturing partner NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced completion of an approximately $1 million investment into a high-volume manufacturing line for...

December 15, 2025
HealthTech Media Room
HealthTech News, News, news

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

ISHI Health, an innovator in AI-enabled virtual cardiac care, announced the launch of its Virtual Heart Failure (HF) Clinics in California and Arizona. The program expands access to HF...

December 15, 2025
HealthTech Media Room
HealthTech News, News, news

Minghui Pharma Gets FDA OK for MHB018A Phase 3 Thyroid Eye Trial

Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, announced the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug...

December 15, 2025
HealthTech Media Room
HealthTech News, News, news

Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development

Rona Therapeutics, a clinical-stage RNAi company, announced the recent completion of Cohort 1 dosing in its Phase 1 first-in-human clinical study of RN3161, an investigational GalNAc-conjugated siRNA targeting INHBE for obesity treatment. Cohort...

December 15, 2025
HealthTech Media Room
HealthTech News, news, News

Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission

The investigational copper histidinate candidate receives new PDUFA Target Action Date of January 14, 2026 Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, announced that the U.S....

December 15, 2025
HealthTech Media Room
HealthTech News, News, news

Dilon Technologies Gets FDA Approval for MarginProbe 2 Launch

Dilon Technologies, a leading provider of medical devices, has gained FDA approval for its MarginProbe 2 system and is announcing its launch in the U.S. This is the next-generation device...

December 15, 2025
HealthTech Media Room
HealthTech News, news

Link Cell Therapies Launches to Advance CAR-T Cancer Treatments

Closes $60 Million Series A Financing Round Backed by New and Existing Investors Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a...

December 15, 2025
HealthTech Media Room
HealthTech News, news, News

Acadia Pharma Gets FDA Approval for DAYBUE STIX Oral Solution

Acadia Pharmaceuticals Inc., has announced that the U.S. Food and Drug Administration has approved DAYBUE STIX, a powder formulation of trofinetide for oral solution, for treating Rett syndrome in...

December 15, 2025
HealthTech Media Room
HealthTech News, news, News

FDA Approves NUZOLVENCE, First-in-Class Gonorrhea Drug

Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc, announced that the U.S. Food and Drug Administration has approved NUZOLVENCE zoliflodacin for oral suspension as a treatment for uncomplicated urogenital...

December 15, 2025
HealthTech Staff Writer
HealthTech News, News, news

NeuraLight Unveils Scientific Leaders Advancing Neurology

NeuraLight, a company focused on developing precision biomarkers for neurological diseases, has announced the appointment of Nobel Prize winning neuroscientist Professor Thomas Südhof as Scientific Co founder and member...

December 15, 2025
Health Tech Staff Writer
HealthTech News, news, News

LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo to EMA

LEO Pharma A S, a global leader in medical dermatology, has submitted an application to the European Medicines Agency requesting an expansion of the approved label for Anzupgo delgocitinib...